Neuland Laboratories Limited — Updates, 12-05-2026: Press Release (Revised)

Neuland Labs reported robust Q4FY26 results: Total Income Rs. 788.7 Cr (+134.9% YoY), EBITDA Rs. 319.4 Cr (+448.6% YoY), and PAT Rs. 212.5 Cr (+666.3% YoY). The company has strong business visibility and is investing in Peptide Manufacturing and a new R&D Centre for future growth.